Physician profile
Vance Harrison Gentry
NPI 1437902111
$1,015.36
in general payments reported to CMS, 2019-2025
8 companies · $995 in 2025
The $995 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $20.15 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.36 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $179.87 | 2025 | Ams 700, Lithoclast |
| Innovation Technologies INC | $154.77 | 2025 | Irrisept |
| Janssen Scientific Affairs, LLC | $150.00 | 2025 | Balversa, Erleada, Akeega |
| Procept Biorobotics Corporation | $135.50 | 2025 | |
| Integra Lifesciences Corporation | $114.36 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Biotech, INC. | $104.33 | 2025 | Erleada, Rybrevant, Carvykti |
| Calyxo, INC. | $97.40 | 2024-2025 | Cvac Aspiration System |
| Teleflex LLC | $79.13 | 2025 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vance Gentry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.